Standard BioTools Price to Book Ratio 2010-2024 | LAB
Historical price to book ratio values for Standard BioTools (LAB) over the last 10 years. The current price to book ratio for Standard BioTools as of November 20, 2024 is 1.15.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Standard BioTools Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-11-19 |
1.51 |
|
1.15 |
| 2024-09-30 |
1.93 |
$1.31 |
1.47 |
| 2024-06-30 |
1.77 |
$1.37 |
1.29 |
| 2023-12-31 |
2.21 |
$2.03 |
1.09 |
| 2023-09-30 |
2.90 |
$2.26 |
1.28 |
| 2023-06-30 |
1.93 |
$2.50 |
0.77 |
| 2023-03-31 |
1.95 |
$2.72 |
0.72 |
| 2022-12-31 |
1.17 |
$2.89 |
0.40 |
| 2024-03-31 |
2.71 |
$1.52 |
1.79 |
| 2022-09-30 |
1.10 |
$3.14 |
0.35 |
| 2022-06-30 |
1.60 |
$3.48 |
0.46 |
| 2022-03-31 |
3.59 |
$0.29 |
12.53 |
| 2021-12-31 |
3.92 |
$1.23 |
3.19 |
| 2021-09-30 |
6.59 |
$1.30 |
5.07 |
| 2021-06-30 |
6.16 |
$1.44 |
4.29 |
| 2021-03-31 |
4.52 |
$1.64 |
2.76 |
| 2020-12-31 |
6.00 |
$1.87 |
3.22 |
| 2020-09-30 |
7.43 |
$2.05 |
3.62 |
| 2020-06-30 |
4.01 |
$1.86 |
2.15 |
| 2020-03-31 |
2.54 |
$2.00 |
1.27 |
| 2019-12-31 |
3.48 |
$2.20 |
1.58 |
| 2019-09-30 |
4.63 |
$2.34 |
1.98 |
| 2019-06-30 |
12.32 |
$2.49 |
4.95 |
| 2019-03-31 |
13.29 |
$2.64 |
5.03 |
| 2018-12-31 |
8.62 |
$1.46 |
5.90 |
| 2018-09-30 |
7.49 |
$0.57 |
13.14 |
| 2018-06-30 |
5.96 |
$0.89 |
6.70 |
| 2018-03-31 |
5.84 |
$1.25 |
4.68 |
| 2017-12-31 |
5.89 |
$0.80 |
7.38 |
| 2017-09-30 |
5.04 |
$1.01 |
4.98 |
| 2017-06-30 |
4.04 |
$0.81 |
4.96 |
| 2017-03-31 |
5.69 |
$1.31 |
4.33 |
| 2016-12-31 |
7.28 |
$1.82 |
3.99 |
| 2016-09-30 |
8.01 |
$2.33 |
3.43 |
| 2016-06-30 |
9.03 |
$2.90 |
3.11 |
| 2016-03-31 |
8.07 |
$3.43 |
2.36 |
| 2015-12-31 |
10.81 |
$3.98 |
2.71 |
| 2015-09-30 |
8.11 |
$4.31 |
1.88 |
| 2015-06-30 |
24.20 |
$4.61 |
5.25 |
| 2015-03-31 |
42.10 |
$4.96 |
8.49 |
| 2014-12-31 |
33.73 |
$5.31 |
6.36 |
| 2014-09-30 |
24.50 |
$5.47 |
4.48 |
| 2014-06-30 |
29.40 |
$5.75 |
5.12 |
| 2014-03-31 |
44.07 |
$5.98 |
7.37 |
| 2013-12-31 |
38.28 |
$3.74 |
10.25 |
| 2013-09-30 |
21.94 |
$3.79 |
5.79 |
| 2013-06-30 |
17.46 |
$3.86 |
4.52 |
| 2013-03-31 |
18.51 |
$3.94 |
4.70 |
| 2012-12-31 |
14.31 |
$4.01 |
3.57 |
| 2012-09-30 |
17.00 |
$4.11 |
4.14 |
| 2012-06-30 |
15.04 |
$2.37 |
6.34 |
| 2012-03-31 |
15.73 |
$2.53 |
6.21 |
| 2011-12-31 |
13.16 |
$2.80 |
4.70 |
| 2011-09-30 |
13.93 |
$2.92 |
4.76 |
| 2011-06-30 |
16.77 |
$3.12 |
5.38 |
| 2011-03-31 |
14.31 |
$3.50 |
4.09 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.562B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
